Evidence map›Paper›PMID 33169421›Full record

ArticleElectrophoresis2021

A novel method of high-purity extracellular vesicle enrichment from microliter-scale human serum for proteomic analysis.

Xiaohui Ji, Sisi Huang, Jie Zhang, Terri F Bruce, Zhijing Tan, Donglin Wang, Jianhui Zhu, R Kenneth Marcus, David M Lubman

Open access · bronzeAbstract read
In one paragraph

Article in Electrophoresis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Osmotic Remodeling of Extracellular Vesicles for Precision Nanomedicine.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Exosome-Based Liquid Biopsy in Early Screening and Diagnosis of Cancers.Dose-response : a publication of International Hormesis Society
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Xiaohui JiDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA.
Sisi HuangDepartment of Chemistry, Biosystems Research Complex, Clemson University, Clemson, SC, USA.
Jie ZhangDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA.
Terri F BruceDepartment of Bioengineering, Life Sciences Facility, Clemson University, Clemson, SC, USA.
Zhijing TanDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA.
Donglin WangChongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, P. R. China.
Jianhui ZhuDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA.ORCID 0000-0002-0051-7777
R Kenneth MarcusDepartment of Chemistry, Biosystems Research Complex, Clemson University, Clemson, SC, USA.ORCID 0000-0003-4276-5805
David M LubmanDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA.ORCID 0000-0001-7731-0232
University of Michigan · USClemson University · USChongqing University · CN

Funding

Supplemental for Detection of Glycopeptides of MCI in Patient SerumR01CA160254 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David M. Lubman · 2012 to 2026
$5.4M
Microsequencing in an Ion Trap/reTOF DeviceR01GM049500 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUBMAN, DAVID M. · 1994 to 2016
$3.0M
Therapeutic Monitoring in Pancreatic Cancer Using an Exosome Based Mass Spec AssayR21CA189775 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUBMAN, DAVID M. · 2015 to 2016
$371k
Discovery and Validation of Biomarkers for Early Cancer Detection Using Mass SpectrometryR50CA221808 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZHU, JIANHUI · 2018 to 2020
$189k
NCI NIH HHS R01 CA160254NCI NIH HHS R21 CA189775NCI NIH HHS R50 CA221808NIGMS NIH HHS R01 GM049500
6 · The paper itself

Abstract

We have developed a rapid, low-cost, and simple separation strategy to separate extracellular vesicles (EVs) from a small amount of serum (i.e.,<100 μL) with minimal contamination by serum proteins and lipoprotein particles to meet the high purity requirement for EV proteome analysis. EVs were separated by a novel polyester capillary channel polymer (PET C-CP) fiber phase/hydrophobic interaction chromatography (HIC) method which is rapid and can process small size samples. The collected EV fractions were subjected to a post-column cleanup protocol using a centrifugal filter to perform buffer exchange and eliminate potential coeluting non-EV proteins while minimizing EV sample loss. Downstream characterization demonstrated that our current strategy can separate EVs with the anticipated exosome-like particle size distribution and high yield (∼1 × 10

Indexed as

Blood ProteinsChromatography, LiquidExtracellular VesiclesHumansHydrophobic and Hydrophilic InteractionsProteomeProteomicsUltracentrifugationBlood ProteinsProteomeCapillary-channeled polymer (C-CP) fibersExtracellular vesiclesHydrophobic interaction chromatography (HIC)Mass spectrometryProteomicsSerum

Identifiers

PMID33169421
PMCPMC8018574
OpenAlexW3100197798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.